Skip to Content

SZ 363 (Repaglinide 2 mg)

Pill with imprint SZ 363 is Yellow, Capsule-shape and has been identified as Repaglinide 2 mg. It is supplied by Sandoz Inc..

Repaglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for SZ 363

Repaglinide

Imprint:
SZ 363
Strength:
2 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Meglitinides
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Inc.
National Drug Code (NDC):
00781-5150

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide